Haleon schedules Toronto Health House as Goldman keeps Buy for Haleon stock
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Haleon is scheduling a "Health House" event in Toronto for October 23, 2026, following a survey of Canadian consumers. This event will showcase brands like Advil and Sensodyne. Goldman Sachs has reiterated its Buy rating for Haleon stock, setting a price target of GBp 460.00, as the company prepares for its Q3 trading statement on October 29, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.